Histone-modifying Enzymes Coregulated in Cancer – a phenomena that can be used for better drug design

4 of the 5 participants in the project, from left to right: Liza, Laura, William and Khademul

Recently epigenetic modifications have drawn lots of attention in the oncology field. Cancer is characterized by aberrant patterns of gene expression of multiple genes. These major shifts in gene expression are believed to be due to genetic and epigenetic changes. Read the rest of this entry »